11/17/20
7 Hills Pharma Receives Orphan Drug Designation for Lead Product, 7HP349, in Treatment of Malignant Melanoma
09/17/20
7 Hills Pharma Receives $2M SBIR Grant from NCI to Launch Phase 1 Trials of Lead Immunostimulant to Augment Immuno-Oncology Drugs, COVID-19 and Flu Vaccines
11/09/20
7 Hills Pharma Announces First Healthy Volunteers Dosed In Landmark Phase 1 Trial of Immunostimulant to Improve Immuno-Oncology Drugs, COVID-19 and Influenza Vaccines
08/28/20
Barda Enlisting Start-Ups In Fight Against COVID-19 Via JLABS Collaboration
04/14/20
7 Hills Pharma Announces FDA Clearance of Investigational New Drug Application for 7HP349, a First-in-Class Immune Stimulant
06/4/20
7 Hills Pharma to Deliver Video Presentation At BIO Digital 2020 June 8 – 12
10/28/20
7 Hill Pharma Names William Schary VP of Clinical & Regulatory Affairs
07/7/20
7 Hills Pharma Announces Positive Data With Oral Immunostimulant to Improve Effectiveness of COVID-19 Vaccines
06/15/20
7 Hills Pharma Highlights Cell Adhesion as Key to Improving Effectiveness of Covid-19 Vaccines and Immuno-Oncology Drugs At BIO Digital 2020 Online Conference
08/3/20
Opinion: Warp Speed to a united or divided America? COVID-19 vaccine trials must include at-risk groups
08/4/20
7 Hills Pharma Awarded Pioneering Patent Estate Covering Integrin Activators to Improve Effectiveness of Immunotherapies
04/15/20
7 Hills Pharma Announces Coronavirus Vaccine Program Targeting At-Risk Elderly
09/5/20
7 Hills Pharma to Participate in Johnson & Johnson Innovation's BLUE KNIGHT™ Collaboration with U.S. Government for its Efforts to Combat COVID-19
12/8/20
Two Incentives that Could Open the Floodgates to Drug Repositioning for COVID-19
07/2021
7 Hills Pharma Names Biopharma Industry Veteran Michael S. Perry Chairman of its Board of Managers
12/7/20
7 Hills Pharma CEO Cites Seniors’ Weakened Immune Systems as Challenge for COVID-19 Vaccines’ Effectiveness
03/2021
IMMUNE ACTIVATORS – Enhancing Cell Adhesion to Safely Improve Effectiveness of Vaccines & Cancer Immunotherapies
06/8/20
7 Hills Pharma Receives $3.5M to Continue Development Of Integrin Activators to Augment Immunotherapies